Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates
Single, High Dose Vitamin A Replacement in Patients Undergoing Hematopoietic Stem Cell Transplantation and Its Role on MBI-LCBI Rates
Sponsor: Children's Hospital Medical Center, Cincinnati
Listed as NCT03039257, this NA trial focuses on Hematopoietic Stem Cell Transplant and remains completed. Sponsored by Children's Hospital Medical Center, Cincinnati, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
Feb 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Medical Center, Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .